Same Indication

Ipilimumab vs Propranolol

Ipilimumab vs Propranolol: Overview

This comparison examines the pharmacological differences between Ipilimumab and Propranolol.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Propranolol: Non-selective beta-adrenergic receptor blocker.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Propranolol — 3-6 hours.

Chemical Properties

Molecular Formula: Propranolol — C16H21NO2.

Molecular Weight: Propranolol — 259.3440 g/mol.

Type: Ipilimumab — Antibody; Propranolol — Small molecule.